Background
Mindfulness based interventions
Why is it important to undertake a review of MBIs?
Methods
Search strategy
Selection criteria
Selection of papers for inclusion
Inclusion criteria | Exclusion criteria | |
---|---|---|
Study design
| Randomised controlled trial, controlled trial | Qualitative studies Single case study Systematic reviews Literature reviews Guidelines Audit |
Population
| Age >18 years Any diagnosis of MS | <18 years old Diseases other than (and not including) MS |
Intervention
| Any specifically mindfulness-based intervention (MBI) | Psychotherapy Drug treatments Manual therapy (ie massage) |
Outcomes
| Perceived stress Anxiety Depression HRQOL Pain Personal wellbeing Social participation |
Study (country) | Study design (setting) | Sample size (attrition %) | Type of intervention (duration) | Outcome measures | Data collection |
---|---|---|---|---|---|
RCT (Patients home) | n = 16 (12.5%) | Mindful breathing Mindful movement (Tai Chi) Self compassion Home study material (6/52 duration) | POMS Standing balance Symptom rating questionnaire | Baseline | |
Post intervention | |||||
3 months post intervention | |||||
RCT (University hospital) | n = 150 (5%) | Mindful breathing Mindful movement (Yoga) Body scan Home study material (8/52 duration) | CES-DSTAI MFIS HAQUAMS PQOLC Neuropsych. | Baseline | |
Post intervention | |||||
6 months post intervention | |||||
CT (University hospital) | n = 17 (43%) | Mindful breathing (Samatha) Mindful movement (Tai Chi) Walking meditation (8/52 duration) | SF-36 MFIS VAS Physical role Vitality PDDS | Baseline | |
Post intervention | |||||
NR |
Quality appraisal
Data extraction
Data synthesis
Results
Study characteristics
Intervention characteristics
Participant characteristics
Mills and Allen [41] | Grossman et al. [40] | Tavee et al. [42] | |
---|---|---|---|
Ethnicity
| NR | NR | NR |
Number of participants (% female)
| 16 (80%) | 150 (80%) | 17 (78%) |
Mean age (SD)
| 49.8 (6.8) | 47.3 (10.3) | 48.7 (11.2) |
Socio-economic status
| NR | NR | NR |
Employment status
| 4 employed (25%) | NR | NR |
Mean years of education (SD)
| NR | 14.1 (1.9) | NR |
Disease phenotype
| SP 16 (100%) | RR 123 (82%) SP 27 (18%) | NR |
Stage in disease progression
| NR | Mean EDSS 3.0 (1.1) | Mean EDSS 3.0 (2.5) |
Comorbidities
| NR | NR | NR |
Number of patients on disease modifying medication
| NR | 91 (60.1%) | NR |
Number of patients on psychotropic medication
| NR | 30 (20%) | NR |
Outcomes
Mental health outcomes
Anxiety
Study | Outcome (measure) | Post intervention effect size (p) | Follow up effect size (p) and time point | |
---|---|---|---|---|
Grossman et al. [40] | Full intervention group | Anxiety (STAI) | 0.39 (0.0006) | 0.36 (0.02) at six months |
Sub-group analysis | 1.00 (0.002) | 0.64 (0.05) at six months | ||
Full intervention group | Depression (CES-D) | 0.65 (0.00001) | 0.36 (0.03) at six months | |
Sub-group analysis | 1.06 (0.0002) | 0.66 (0.03) at six months | ||
Mills and Allen [41] | Anxiety (POMS) | p > 0.05* | p > 0.05* | |
Depression (POMS) | p < 0.01* | NR |
Depression
Physical outcomes
Standing balance
Study | Outcome (measure) | Post intervention effect size (p) | Follow up effect size (p) and time point | |
---|---|---|---|---|
Grossman et al. [40] | Full intervention group | Fatigue (MFIS) | 0.41 (0.0001) | 0.38 (0.001) at six months |
Sub-group analysis | 1.27 (0.0005) | 1.09 (0.02) at six months | ||
Mills and Allen [41] | Fatigue (POMS) | p > 0.05* | NR | |
Single leg standing balance | p < 0.05* | p < 0.05* at three months | ||
Tavee et al. [42] | Fatigue (MFIS) | p = 0.035* | NR | |
Pain (VAS) | p = 0.031* | NR | ||
PDDS | p > 0.05* | NR |
Pain
Fatigue
Psychosocial outcomes
Study | Measure | Post intervention effect size (p) | Follow up effect size (p) and time point | |
---|---|---|---|---|
Grossman et al. [40] | Full intervention group | HAQUAMS | 0.43 (0.0002) | 0.28 (0.04) at six months |
PQOLC | 0.86 (0.00000001) | 0.51 (0.03) at six months | ||
Sub-group analysis | HAQUAMS | 1.01 (0.0001) | 0.58 (0.04) at six months | |
PQOLC | 1.71 (0.00000001) | 0.51 (0.003) at six months |
Methodological quality of included papers
Grossman et al. [40] | Mills and Allen [41] | Tavee et al. [42] | |
---|---|---|---|
Random sequence generation (selection bias) | Low | Unclear | NA |
Allocation concealment (selection bias) | Low | Unclear | NA |
Blinding of assessors (performance bias) | Low | Unclear | High |
Blinding of outcome assessment (detection bias) (patient reported outcomes) | High | High | High |
Incomplete outcome data addressed (attrition bias) | Low | Unclear | High |
Selective outcome reporting (reporting bias) | Low | High | Unclear |
Other sources of bias (ie baseline bias) | Low | Unclear | Unclear |